Alnylam Pharmaceuticals | ALNY - 股票

股票价格

311.10

每天变化

-3.70 -1.18%

每月一次

-7.46%

每年

22.70%

Q1 预测

303.95

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 40.65B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	股票	更改		日
Acadia Pharmaceuticals	USD 34.67M		5.57M	2025-12
Agios Pharmaceuticals	USD 32.92M		886K	2025-12
Alnylam Pharmaceuticals	USD 82.72M		7.34M	2025-12
Amgen	USD 6.22B		121M	2025-12
Arrowhead Research	USD -173.08M		173.08M	2024-12
BioCryst Pharmaceuticals	USD 5.4M		166K	2025-12
BioMarin Pharmaceutical	USD 1.3B		83.29M	2025-12
Incyte	USD 101.06M		17.61M	2025-12
Ionis Pharmaceuticals	USD 10.47M		1.99M	2025-09
Moderna	USD 332M		92M	2025-09
Neurocrine Biosciences	USD 69M		300K	2025-12
Novartis	USD 6.42B		114M	2025-09
PTC Therapeutics	USD 79.65M		26.96M	2025-12
Regeneron Pharmaceuticals	USD 3.2B		53.6M	2025-12
Sanofi	EUR 22.69B		1.81B	2025-12
Sarepta Therapeutics	USD 914.74M		162.42M	2025-12
Takeda	JPY 1.41T		107.71B	2025-12
Ultragenyx Pharmaceutical	USD 52.2M		5.7M	2025-09
Vertex Pharmaceuticals	USD 1.69B		60M	2025-12